180 related articles for article (PubMed ID: 5056771)
1. How dangerous are oral contraceptives?
Jordaan HV
S Afr Med J; 1972 Aug; 46(34):1215-7. PubMed ID: 5056771
[No Abstract] [Full Text] [Related]
2. Complications of systemic oral contraceptive therapy: Neoplasm--breast, uterus, cervix and vagina.
Sperling MA
West J Med; 1975 Jan; 122(1):42-9. PubMed ID: 1089006
[No Abstract] [Full Text] [Related]
3. Cervical carcinoma and oral contraception.
Boyce JG; Lu T; Nelson JH; Joyce D
Obstet Gynecol; 1972 Aug; 40(2):139-46. PubMed ID: 5047946
[No Abstract] [Full Text] [Related]
4. When to discontinue oral contraceptives.
Board JA
Va Med Mon (1918); 1970 Oct; 97(10):623-7. PubMed ID: 4950744
[No Abstract] [Full Text] [Related]
5. Endometrial carcinoma and oral contraceptive agents.
Cohen CJ; Deppe G
Obstet Gynecol; 1977 Apr; 49(4):390-2. PubMed ID: 193073
[TBL] [Abstract][Full Text] [Related]
6. Oral contraceptives and endometrial and cervical cancer.
Moghissi KS
J Toxicol Environ Health; 1977 Sep; 3(1-2):243-65. PubMed ID: 336901
[No Abstract] [Full Text] [Related]
7. Oral contraceptives and endometrial carcinoma: Case for progesterone-receptor defect.
Jansen RP; Elliott PM
Lancet; 1977 Mar; 1(8011):602-3. PubMed ID: 65687
[No Abstract] [Full Text] [Related]
8. Adenocarcinoma of the endometrium in women taking sequential oral contraceptives.
Kelley HW; Miles PA; Buster JE; Scragg WH
Obstet Gynecol; 1976 Feb; 47(2):202-2. PubMed ID: 1250543
[TBL] [Abstract][Full Text] [Related]
9. Atypical reserve cell hyperplasia of cervical glands, simulating adenocarcinoma. An undescribed reversible lesion in a woman taking oral contraceptives.
Filotico M; Grasso S
Tumori; 1981 Oct; 67(5):491-6. PubMed ID: 7324178
[No Abstract] [Full Text] [Related]
10. Cancer risks from estrogen intake.
Greenwald P; Nasca PC; Caputo TA; Janerich DT
N Y State J Med; 1977 Jun; 77(7):1069-74. PubMed ID: 267252
[No Abstract] [Full Text] [Related]
11. Relationship of oral contraceptives to cervical carcinogenesis.
Thomas DB
Obstet Gynecol; 1972 Oct; 40(4):508-18. PubMed ID: 5073446
[No Abstract] [Full Text] [Related]
12. [Lesions of the uterine cervix during oral contraception].
De Brux J
Sem Hop; 1974 May; 50(22):1491-5. PubMed ID: 4369604
[No Abstract] [Full Text] [Related]
13. Exogenous estrogens and endometrial carcinoma.
Reeves KO; Kaufman RH
J Reprod Med; 1977 Jun; 18(6):297-300. PubMed ID: 881682
[No Abstract] [Full Text] [Related]
14. Experimental and clinical aspects of the carcinogenic potential of steroid contraceptives.
Hertz R
Int J Fertil; 1968; 13(4):273-86. PubMed ID: 4882601
[No Abstract] [Full Text] [Related]
15. Incidence of endometrial cancer in relation to the use of oral contraceptives.
Weiss NS; Sayvetz TA
N Engl J Med; 1980 Mar; 302(10):551-4. PubMed ID: 7351890
[TBL] [Abstract][Full Text] [Related]
16. Estrogens and cancer of the female reproductive system.
Boyce JG
Urban Health; 1977 Apr; 6(3):14-5, 56. PubMed ID: 10235882
[No Abstract] [Full Text] [Related]
17. [Adenocarcinoma of the cervix and the use of oral contraceptives].
Dtsch Med Wochenschr; 1995 Sep; 120(39):1341. PubMed ID: 7555649
[No Abstract] [Full Text] [Related]
18. Oral contraceptives and thromboembolism.
Med Lett Drugs Ther; 1972 Aug; 14(17):61-2. PubMed ID: 4567564
[No Abstract] [Full Text] [Related]
19. Oral contraceptives and endometrial cancer.
Cole P
N Engl J Med; 1980 Mar; 302(10):575-6. PubMed ID: 7351894
[TBL] [Abstract][Full Text] [Related]
20. [Exogenous estrogens and carcinoma of the endometrium: a critical analysis of the literature].
Franceschi S; La Vecchia C
Ann Ostet Ginecol Med Perinat; 1980; 101(6):397-403. PubMed ID: 7008676
[No Abstract] [Full Text] [Related]
[Next] [New Search]
